By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Institute on Drug Abuse (NIDA) 

6001 Executive Boulevard

Bethesda  Maryland  20892-9561  U.S.A.
Phone: 301-443-1124 Fax:


SEARCH JOBS


Industry
Government






Company News
Embera NeuroTherapeutics, Inc. Receives $11M Grant From National Institute on Drug Abuse (NIDA) For The Clinical Development Of EMB-001 For The Treatment Of Cocaine Addiction 7/26/2016 9:47:46 AM
Cerecor Inc. Announces $1.0 Million Research & Development Grant From The National Institute on Drug Abuse (NIDA) At The NIH 4/11/2016 8:34:11 AM
Eagle Pharma (EGRX) And NIH (NIH/National Institute on Drug Abuse (NIDA)) Enter Into Agreement To Explore Use Of Ryanodex In MDMA (Ecstasy) And Methamphetamine Intoxication 3/28/2016 9:48:09 AM
Sosei Group Corporation Subsidiary Heptares Awarded $5.5 Million Research & Development Grant From National Institute on Drug Abuse (NIDA) 9/28/2015 1:18:02 PM
Savant HWP Announces National Institute on Drug Abuse (NIDA) Funding For Pre-Clinical Development Of 18-MC As Potential Treatment For Addiction, Obesity 6/26/2015 1:25:48 PM
Cortex Pharmaceuticals, Inc. (COR) Announces Phase 1 Funding By The National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) Under The Small Business Innovation Research Funding Award Program 9/24/2014 7:42:30 AM
Technical Resources International, Inc. And Nuventra Pharma Sciences To Provide Pharmacokinetic And Pharmacodynamic Services To The National Institute on Drug Abuse (NIDA) 7/8/2014 6:40:27 AM
Initial Data From Lightlake Therapeutics Inc. (LLTP) Joint Clinical Trial With National Institute on Drug Abuse (NIDA) Shows Nasal Delivery Of Naloxone For Opioid Overdose As A Promising Treatment 12/4/2013 11:10:42 AM
Addex Therapeutics (ADXN.SW) and National Institute on Drug Abuse (NIDA) Enter Collaboration to Advance ADX71441 & ADX88178 in Drug Abuse and Addiction 11/4/2013 9:39:09 AM
Lightlake Therapeutics Inc. (LLTP) Commences Two-Week Patient Trial for Treatment of Opioid Overdose With National Institute on Drug Abuse (NIDA) 9/24/2013 10:14:15 AM
12345
//-->